Renal Failure & Liver Failure
Understanding the kidney–liver connection, why kidney function worsens in cirrhosis, and when simultaneous liver–kidney transplant (SLK) becomes necessary.
→ Portal Hypertension & Cirrhosis
Overview
Kidney dysfunction is extremely common in cirrhosis and strongly impacts transplant urgency, hospital survival, and long-term outcomes \[1–3\]. In advanced liver failure, even small disruptions—bleeding, infection, dehydration, medications—can trigger rapid kidney decline.
Some kidney injuries are reversible with proper treatment. Others reflect lasting structural disease. Differentiating these patterns is crucial when deciding between liver transplant alone or simultaneous liver–kidney (SLK) transplant \[2–4\].
How Liver & Kidneys Are Linked
Cirrhosis causes portal hypertension and dilation of abdominal blood vessels, which lowers effective blood volume despite total body fluid overload \[1,2\]. The body responds by constricting blood flow to the kidneys and retaining salt and water.
This delicate balance can collapse when infections, over-diuresis, bleeding, contrast dye, or NSAIDs are introduced \[2–4\]. Kidney failure in cirrhosis is therefore often functional and hemodynamic, especially early on.
Acute Kidney Injury (AKI) in Cirrhosis
- Pre-renal AKI from low effective blood volume
- ATN from sepsis, shock, or toxins
- Hepatorenal syndrome (HRS)
- Obstruction or other intrinsic disease
Early treatment targets volume expansion, albumin when appropriate, treating infections, stopping nephrotoxins, and stabilizing blood pressure \[2–4\].
Hepatorenal Syndrome (HRS)
HRS is a functional kidney failure that occurs in advanced cirrhosis—kidneys are structurally normal but blood flow is extremely reduced \[1–3\].
Treatment includes albumin + vasoconstrictors (terlipressin where available), infection control, and avoiding nephrotoxins. Liver transplant is the only definitive therapy.
Other Kidney Problems
- Diabetic nephropathy
- Hypertensive kidney disease
- Glomerulonephritis (viral, autoimmune)
- Drug toxicity (calcineurin inhibitors, NSAIDs, antibiotics)
Proteinuria, hematuria, or small echogenic kidneys suggest intrinsic CKD and may push consideration toward SLK \[4–5\].
Simultaneous Liver–Kidney Transplant (SLK)
SLK is considered when kidney dysfunction is prolonged, structural, or unlikely to recover after liver-only transplant \[4–6\].
- Dialysis ≥6 weeks (varies by region)
- Persistently low eGFR over specified duration
- Evidence of intrinsic CKD (biopsy, small kidneys, proteinuria)
Patients with short-term HRS or AKI may recover kidney function after liver transplant alone.
Dialysis While Awaiting Transplant
Dialysis stabilizes potassium, acid–base balance, and volume status but does not reverse the underlying liver disease \[2–5\]. Both intermittent and continuous forms may be used depending on blood pressure stability.
Some patients recover kidney function after liver-only transplant; others remain dialysis-dependent and may need later kidney transplant.
Kidney Problems After Liver Transplant
- Calcineurin inhibitor nephrotoxicity
- Recurrent diabetes, hypertension
- Residual pre-transplant injury
- Sepsis or hypotension episodes
Long-term kidney protection includes BP control, avoiding nephrotoxins, adjusting immunosuppression, and monitoring GFR \[6–7\].
Living With Both Liver & Kidney Disease
- Avoid NSAIDs
- Control BP, glucose, cholesterol
- Manage sodium and fluid intake
- Report decreased urine output immediately
- Attend all labs and follow-up visits
Support from nutrition, pharmacy, nephrology, and social work is essential.
Questions to Ask Your Team
- Is my kidney injury reversible?
- Do I meet criteria for SLK?
- How will you protect my kidneys until transplant?
- Will I recover kidney function after liver-only transplant?
- If I need dialysis, which type is safest for me?
References
- Ginès P, Schrier RW. Pathophysiology of renal failure in cirrhosis.
- ICA consensus on AKI/HRS definitions.
- AASLD guidelines on decompensated cirrhosis.
- UNOS/OPTN policies on SLK allocation.
- EASL guidance on CKD in cirrhosis.
- Studies on renal recovery after liver-only transplant.
- Calcineurin inhibitor nephrotoxicity data.
